NeuroMetrix is a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. The Company has three FDA cleared commercial products. DPNCheck® is a point-of-care test that is used to evaluate peripheral neuropathies. ADVANCE™ is a point-of-care device that provides nerve conduction studies as an aid in diagnosing and evaluating patients suspected of having focal or systemic neuropathies. Quell® 2.0 is a wearable, mobile app enabled, neurostimulation device indicated for symptomatic relief and management of chronic pain and is available OTC. The Company maintains an active, industry-leading R&D program.
Events & Presentations
Apr 22, 2021 at 8:00 AM EDT
Q1 2021 NeuroMetrix Inc. Earnings Conference Call
Jan 28, 2021 at 8:00 AM EST
Q4 and Year-End 2020 NeuroMetrix Inc. Earnings Conference Call